MarkWide Research - Global Market Intelligence Platform
Report Details
Historical Year
2020-2024
Base Year
2025
Forecast Period
2026-2036
Published Date
May 2026
No. of Pages
266 Pages
Delivery Format
PDF + Excel
Home›Industries›Healthcare›Healthcare Services›Hospice and Palliative Care Centers Market

Hospice and Palliative Care Centers Market Size, Share, and Industry Trends Forecast 2026-2036

The Hospice and Palliative Care Centers Market valued at $64.7 Billion in 2026 is projected to expand to $135.95 Billion by 2035, advancing at a 8.60% CAGR over the analysis window. Medicare hospice benefit expansion is accelerating service adoption among geriatric populations. Telehealth integration is reshaping rural access models. Demand concentrates in the United States, where fee-for-service and value-based reimbursement structures coexist.

Hospice and Palliative Care Centers Market Outlook

The Medicare Hospice Benefit is decoupling palliative access from acute-care infrastructure, redirecting patient flows toward community-based models. VITAS Healthcare leverages its scale across multiple states to sustain inpatient capacity while expanding home-based reach. Amedisys anchors its position through home health-hospice integration, controlling referral pipelines from hospital discharge planners. Gentiva Health Services competes on geographic density, occupying markets where Medicare Advantage penetration is deepest.

Hospice and palliative care centers deliver interdisciplinary symptom management, psychosocial support, and bereavement services to patients with life-limiting conditions, typically operating under Medicare Conditions of Participation that mandate physician oversight, nursing coverage, and volunteer coordination. Home care commands the largest service volume as patients seek death outside institutional settings, while telehealth delivery is expanding fastest where workforce shortages constrain on-site capacity. Medicare and Medicaid together dominate funding sources, though private insurance represents the most contested margin pool as employers add hospice riders to commercial plans.

The Centers for Medicare & Medicaid Services shapes demand through hospice payment reform and quality reporting mandates, while state Medicaid agencies determine eligibility breadth for dual-eligible populations. The Joint Commission and Community Health Accreditation Partner maintain voluntary standards that influence payer network participation and hospital partnership terms. Stakeholders must monitor whether CMS accelerates value-based hospice models that would reward reduced hospitalization rates over per-diem volume.

Hospice and Palliative Care Centers Market Size and Forecast

Market Dynamics

Medicare's hospice payment reform is decoupling reimbursement from acute-care bed days, redirecting capital toward home-based infrastructure and telehealth platforms that extend rural reach without bricks-and-mortar expansion.

Growth Catalysts

  • Telehealth parity mandates:CMS reimbursement codes now cover remote patient monitoring for hospice eligibility assessments, eliminating geographic access barriers for isolated populations.
  • Dual-eligible enrollment expansion:State Medicaid agencies in Texas, Florida, and Ohio are broadening hospice carve-outs for low-income seniors previously excluded from community-based death.
  • Hospital-at-home waivers:The Center for Medicare & Medicaid Innovation is testing hospice-inclusive bundled payments that discharge terminal patients directly to residential settings.

Market Restraints

  • Registered nurse supply contraction:The Bureau of Labor Statistics projects persistent shortages in geriatric-trained RNs, inflating labor costs for 24/7 on-call coverage mandates.
  • Hospice fraud enforcement:The Department of Justice's Medicare Fraud Strike Force is intensifying scrutiny of election statement documentation, elevating compliance overhead.
  • Opioid prescribing restrictions:DEA production quotas for Schedule II analgesics are compressing formulary flexibility for pain management protocols.

Strategic Opportunities

  • Medicare Advantage hospice carve-ins:CMS is permitting MA plans to integrate hospice benefits, creating capitated revenue streams outside traditional fee-for-service.
  • Veterans Affairs community partnerships:The VA is outsourcing palliative capacity to civilian providers under the Veterans Community Care Program.
  • AI-driven symptom prediction:Machine learning platforms that forecast crisis trajectories are expanding into hospice triage, enabling proactive nursing deployment.

Industry Challenges

  • Volunteer coordinator recruitment:Medicare Conditions of Participation mandate 5% volunteer hours, yet civic participation rates are declining in aging communities.
  • EMR interoperability gaps:Hospice-specific platforms lack seamless data exchange with hospital discharge systems, delaying referral handoffs.

Report Scope

MarkWide Research
AttributesDetails
Report TitleHospice and Palliative Care Centers Market
Market Size in 2026$64.7 Billion
Market Size in 2035$135.95 Billion
CAGR (2026 – 2036)8.6%
Historical Year2020-2024
Base Year2025
Forecast Period2026-2036
Segmentation
Service Type: Inpatient Care, Outpatient Care, Home Care, Respite Care
Delivery Mode: Telehealth, On-site, Mobile Unit, Community-Based
Patient Type: Pediatric, Geriatric, Terminal Illness, Chronic Illness
Funding Source: Private Insurance, Medicare, Medicaid, Out-of-Pocket
Companies CoveredGentiva Health Services, Seasons Hospice & Palliative Care, VITAS Healthcare, Humana Hospice, Capital Caring Health, Amedisys, Kindred at Home, New Century Hospice, Compassus, Others
Regions Covered
North America: US, Canada, Mexico
Europe: Germany, Italy, France, UK, Spain, Denmark, Sweden, Austria, Belgium, Finland, Turkey, Poland, Russia, Greece, Switzerland, Netherlands, Norway, Portugal, Rest of Europe
Asia Pacific: China, Japan, India, South Korea, Indonesia, Malaysia, Kazakhstan, Taiwan, Vietnam, Thailand, Philippines, Singapore, Australia, New Zealand, Rest of Asia Pacific
South America: Brazil, Argentina, Colombia, Chile, Peru, Rest of South America
Middle East & Africa: Saudi Arabia, UAE, Qatar, South Africa, Israel, Kuwait, Oman, North Africa, West Africa, Rest of MEA

Get the full picture before you read further.

Download a free sample with table of contents, companies, segments, and methodology.

Hospice and Palliative Care Centers Market Strategic Shifts

Technology integration is restructuring how palliative services are delivered, measured, and reimbursed across institutional and residential boundaries.

Remote physiological monitoring systems are expanding into home hospice settings, capturing vital signs and symptom scores through wearable sensors and tablet-based patient reporting. Rural hospices in Montana and Alaska are adopting these platforms fastest, where travel distances previously forced institutionalization. The technology is expanding into predictive analytics that flag impending crises 24-48 hours before emergency department utilization.

CMS's Hospice Quality Reporting Program is mandating standardized family caregiver experience surveys and patient-level functional assessments, with public reporting scheduled for 2027. This regulatory pressure is forcing EMR vendors to embed CAHPS-compliant data capture into workflow design. Smaller community-based hospices in the Southeast are consolidating to afford compliance infrastructure.

Family caregivers are assuming clinical tasks previously reserved for licensed staff, including medication administration and wound care, as hospital discharge planners prioritize home death preferences. Hospice agencies are responding with structured training protocols and 24/7 nurse hotlines to support this delegation. California and Washington are witnessing the fastest adoption of caregiver certification programs that formalize this shift.

Hospice and Palliative Care Centers Market Segmentation

Hospice and Palliative Care Centers Market Segment

Segmentation in hospice and palliative care reveals how reimbursement structures and patient preferences fragment service delivery across institutional and residential boundaries. Understanding these divisions exposes where capital flows concentrate and which models CMS policy is actively reshaping.

Service Type:

Volume concentrates in home-based models, while inpatient capacity commands premium per-diem rates for crisis stabilization and symptom complexity.

  • Home Care:Delivers nursing visits, aide support, and volunteer coordination to private residences under Medicare's routine home care rate structure. Demand clusters in Florida, Arizona, and Texas where retiree density and Medicaid hospice carve-outs overlap. CMS's 24/7 nursing availability mandate drives labor cost escalation in dispersed rural markets.
  • Inpatient Care:Provides 24-hour skilled nursing in dedicated hospice units or contracted hospital beds for uncontrolled pain or acute symptom crises. General acute care hospitals in California and New York maintain the highest concentration of hospice-designated beds. Medicare's general inpatient rate, roughly triple the home care per-diem, attracts capital despite occupancy volatility.
  • Outpatient Care:Clinic-based symptom management and advance care planning for patients not yet hospice-eligible. Palliative care clinics at Cleveland Clinic and Mayo anchor this segment in major metropolitan corridors.
  • Respite Care:Short-term institutional stays providing caregiver relief, capped at five consecutive days under Medicare benefit rules. Demand spikes correlate with dementia progression trajectories in Medicare Advantage populations.

Today's leader: Home Care. Tomorrow's challenger: Inpatient Care.

Delivery Mode:

Geographic isolation and workforce scarcity are accelerating technology-mediated delivery models fastest where physical infrastructure cannot scale.

  • Telehealth:Remote eligibility assessments, crisis triage, and bereavement counseling delivered via video platforms and remote monitoring devices. Montana and Alaska hospices adopted these platforms earliest to serve frontier populations. CMS's permanent telehealth parity for hospice physician visits eliminates prior geographic restrictions.
  • On-site:Traditional facility-based delivery in dedicated hospice houses, hospital units, or nursing home embedded teams. The Joint Commission accredits approximately 4,000 on-site programs nationwide.
  • Mobile Unit:Roving clinical teams serving homeless populations, correctional facilities, and rural dispersed communities. Los Angeles County's mobile palliative program exemplifies this model's reach into housing-insecure terminal patients.
  • Community-Based:Volunteer-driven comfort care in non-clinical settings including churches, community centers, and family homes. Medicare's 5% volunteer hour mandate structurally embeds this mode across all certified agencies.

Telehealth is gaining share fastest where RN supply constraints bite deepest.

Patient Type:

Medicare eligibility criteria and reimbursement rates stratify service intensity across age and prognosis categories.

  • Geriatric:Adults 65+ with terminal prognoses, representing the dominant volume pool under traditional Medicare fee-for-service. Alzheimer's disease and COPD now outpace cancer as primary diagnoses in this cohort.
  • Terminal Illness:Patients with physician-certified six-month or less prognosis across all age groups, meeting Medicare's hospice election requirements. CMS's concurrent care demonstration permits curative treatment continuation for certain diagnoses.
  • Pediatric:Infants, children, and adolescents with life-limiting conditions, served through Medicaid's Katie Beckett waiver programs and the Children's Health Insurance Program. Medicaid covers curative and palliative services simultaneously, unlike Medicare's stricter election requirements.
  • Chronic Illness:Patients with serious but not imminently terminal conditions receiving palliative care alongside disease-modifying treatment. Medicare Advantage plans increasingly carve in these benefits under value-based contracts.

Geriatric volume dominates current revenue. Chronic Illness is expanding most quickly as payers integrate palliative upstream of hospice election.

Funding Source:

Reimbursement source determines margin structure, compliance burden, and competitive positioning across the provider landscape.

  • Medicare:Federal health insurance for aged and disabled populations, funding approximately 85% of hospice days through per-diem payments tiered by care level. The Medicare Hospice Benefit's four levels—routine home care, continuous home care, general inpatient care, and inpatient respite—create rate differentiation without service line fragmentation.
  • Medicaid:State-administered programs for low-income populations, with hospice benefits varying by state eligibility rules and carve-out structures. Texas, Ohio, and Florida expanded Medicaid hospice access most aggressively for dual-eligible populations.
  • Private Insurance:Employer-sponsored and individual commercial plans, representing the most contested margin pool as hospice riders proliferate in large group markets. UnitedHealthcare and Aetna now include hospice in standard benefit designs for self-insured employers.
  • Out-of-Pocket:Direct patient or family payment for non-covered services including private duty nursing beyond Medicare's intermittent visit definition, luxury amenities in residential facilities, and integrative therapies. Wealth concentrations in coastal metropolitan areas sustain this segment's viability.

Medicare anchors current volume. Private Insurance offers the steepest expansion trajectory as employers redesign benefit packages.

Hospice and Palliative Care Centers Market Segmentation

Need this report tailored to your region?

Request specific countries, segments, or companies — tailored to your requirements.

Regional Outlook

The modern hospice movement traces its institutional roots to the United Kingdom, where St. Christopher's Hospice established the interdisciplinary care model in 1967 before spreading to North America and beyond.

United States

Medicare's hospice benefit expansion and dual-eligible enrollment growth in Texas, Florida, and Ohio drive service volume acceleration. CMS Conditions of Participation mandate physician oversight and 24/7 nursing availability, elevating compliance infrastructure requirements. The Medicare Advantage hospice carve-in pilot is reshaping reimbursement flows in metropolitan Phoenix and Miami, where capitated models now compete with fee-for-service dominance.

United Kingdom

NHS England's Long Term Plan prioritizes community-based end-of-life care, diverting patients from acute hospital deaths. The Care Quality Commission enforces hospice registration standards that influence charitable funding eligibility. Marie Curie and Sue Ryder operate substantial networks across Greater London and the West Midlands, where hospice-at-home services now exceed inpatient bed days.

Germany

Statutory health insurance hospice coverage expansion and palliative care specialization training mandates address aging demographic pressure. The Federal Joint Committee (G-BA) determines reimbursement rates for outpatient and inpatient hospice services. Specialized palliative units in university hospitals across Bavaria and North Rhine-Westphalia anchor clinical training pipelines for Central European workforce development.

Japan

Super-aging society demographics and the 2018 Cancer Control Act implementation accelerate hospice bed expansion targets. The Ministry of Health, Labour and Welfare certifies designated cancer care hospitals for integrated palliative services. Hospice facilities in the Kanto region surrounding Tokyo concentrate specialized dementia palliative capacity as neurodegenerative diagnoses multiply.

Australia

Palliative Care Australia national standards and state-based hospice funding models create heterogeneous service availability. The Aged Care Quality and Safety Commission oversees residential aged care palliative integration. Community hospice providers in New South Wales and Victoria pioneer telehealth-supported rural delivery where specialist workforce scarcity previously forced institutionalization.

Hospice and Palliative Care Centers Market Competitive Environment

Premium-margin players sit above commodity-margin players across geographic density and payer mix diversification, with scale-driven networks commanding preferred status in Medicare Advantage corridors while regional specialists defend position through hospital discharge relationships. The vendor base organizes into three archetypes: national platforms with multi-state footprints, regional consolidators with deep local referral pipelines, and specialized pediatric or disease-focused operators. M&A activity concentrates on Medicare Advantage penetration markets, while telehealth infrastructure investment separates capital-rich acquirers from legacy-dependent targets.

Among national-scale operators, VITAS Healthcare and Amedisys exemplify divergent strategic positioning within the Medicare-centric tier. VITAS Healthcare represents the inpatient-anchored model sustaining crisis-stabilization capacity across multiple states. Amedisys occupies the home health-hospice integration archetype, controlling referral flows from hospital discharge planners through combined service offerings. Gentiva Health Services anchors the geographic density strategy, concentrating presence in markets where Medicare Advantage penetration enables value-based contracting experimentation.

Leading Market Players
Gentiva Health Services
Seasons Hospice & Palliative Care
VITAS Healthcare
Humana Hospice
Capital Caring Health
Amedisys
Kindred at Home
New Century Hospice
Compassus
Others
Please Note: The list provided is preliminary and subject to refinement. Our final study will profile 15–20 companies, and we are happy to customize the selection to align with your specific needs.

Value Chain & Pricing Dynamics

CMS's hospice payment reform mandating value-based quality metrics is forcing providers to restructure cost allocation across labor-intensive service tiers, compressing margins in routine home care while elevating reimbursement rates for crisis-stabilization capacity.

Pricing Analysis

Per-diem reimbursement tiered across four Medicare care levels structures hospice pricing, with general inpatient rates commanding triple the routine home care rate. Price differentiation rests on staffing intensity and geographic accessibility, not brand premium. Cost compression in routine home care is intensifying because RN supply constraints inflate 24/7 on-call coverage costs. Medicare Advantage enrollees show lowest price sensitivity due to capitated benefit design, while Medicaid-dependent populations in non-expansion states face highest out-of-pocket exposure.

Supply Chain Analysis

Medical equipment returns and pharmaceutical waste flows from deceased patients create reverse-logistics complexity unique to hospice operations. Clinical supply chains draw from domestic pharmaceutical distributors, durable medical equipment lessors, and specialized compounding pharmacies concentrated in Florida, Texas, and California. Opioid dispensing restrictions tether formulary flexibility to DEA production quotas. Single-source vulnerability runs through generic injectable analgesics. Distribution runs through GPO-affiliated wholesalers serving hospital-embedded hospice units and independent community-based agencies.

Hospice and Palliative Care Centers Market SWOT Analysis

Get the full picture before you read further.

Download a free sample with table of contents, companies, segments, and methodology.

Analyst Recommendations

This market compounds returns through regulatory tailwinds, with CMS's Medicare Advantage hospice carve-in pilot expanding addressable revenue pools beyond traditional fee-for-service constraints.

For Market Incumbents: Anticipate workforce scarcity by anchoring triage capacity in telehealth platforms and securing exclusive referral contracts with hospital discharge planners in Medicare Advantage penetration corridors. Consolidate geographic density in Texas, Florida, and Ohio where dual-eligible enrollment expansion is fastest. Defensive moats deepen through backward integration into home health services that control upstream patient identification. For New Entrants and Emerging Players: CMS's rural health clinic telehealth parity in frontier states opens a window for technology-enabled hospice models bypassing bricks-and-mortar infrastructure. Target Montana and Alaska markets where travel distances previously forced institutionalization and RN supply constraints are most acute. White-space exists in mobile palliative units serving homeless and correctional populations in Los Angeles County-style deployments. Go-to-market leverage rests on AI-driven symptom prediction platforms that reduce emergency department utilization rates. For Investors and Strategic Acquirers: Asymmetric upside sits with regional consolidators possessing deep hospital discharge relationships and untapped Medicare Advantage contracting capacity. Long-term viability favors platforms integrating home health-hospice service lines that capture patients upstream of terminal prognosis. Acquisition targets should demonstrate compliance infrastructure for CMS's 2027 quality reporting mandates. Monitor state Medicaid agency hospice carve-out decisions as inflection signals for dual-eligible volume acceleration.
Strategic Initiative Industry Significance
Telehealth Infrastructure Deployment CMS reimbursement parity for remote hospice physician visits eliminates geographic access barriers in frontier markets.
Home Health-Hospice Integration Combined service offerings control referral pipelines from hospital discharge planners and upstream patient identification.
Medicare Advantage Contracting Capitated revenue streams in Phoenix and Miami corridors reduce per-diem volume dependency.
AI-Driven Symptom Prediction Machine learning platforms forecasting crisis trajectories enable proactive nursing deployment and reduce emergency utilization.
State Medicaid Carve-Out Expansion Texas and Ohio eligibility broadening captures previously excluded low-income seniors in community-based death models.

Study Parameters

Bottom-up service-type modeling reconciled against top-down payer-mix tracking forms the analytical core of this study. Primary interviews with hospice agency executives, Medicare compliance officers, hospital discharge planners, and state Medicaid policy leads combined with secondary validation from CMS Medicare cost reports, state hospice licensure databases, and Medicare Advantage plan benefit filings. Triangulation across stakeholder perspectives and administrative data sources ensures coverage of both regulated reimbursement structures and operational cost drivers.

Historical trendline analysis of per-diem rate evolution and service volume shifts across the projection horizon informs the forecast framework. Segmentation dimensions modeled include service type, delivery mode, patient category, and funding source, with geographic payer-mix variation as an additional industry-specific dimension. CAGRs derive from regression analysis of Medicare enrollment trajectories, dual-eligible population growth, and telehealth adoption curves. Forecast inputs incorporate RN supply projections from Bureau of Labor Statistics and CMS quality reporting compliance timelines.

Revisions become necessary when Medicare payment reform accelerates value-based models or state Medicaid hospice eligibility rules shift materially. Forecasts reflect assumptions about regulatory stability and workforce supply continuity. Practitioners should monitor CMS Innovation Center bundled payment pilots and DEA opioid quota adjustments for early signals.

Need Custom Data?

Can't find what you're looking for? Our analysts can build a custom report tailored to your exact requirements.

1,000+

Global Clients

150+

Countries Covered

65,000+

Reports Available

Frequently Asked Questions

Why Work With MWR

Trusted by 1,000+ businesses across 150+ countries for high-stakes market decisions.

Ready to access intelligence that moves business?

Browse Reports →

Trusted by Global Leaders

From Fortune-level organizations to global SMEs, we provide intelligence for high-stakes decisions.

Multi-Language Support

Research available in French, German, Spanish, Chinese, and more.

ISO & IAF Certified

Globally aligned quality standards ensuring methodological discipline and data integrity.

Competitive Relevance

Free inclusion of 3–4 additional companies of your choice in every report.

Customized Insights

Tailored intelligence for market entry, niche expansion, or competitive benchmarking.

Post-Sale Assistance

Dedicated coordination to help interpret findings and address queries post-delivery.

Cutting-Edge Methods

Structured data collection, advanced analytics, and expert validation for reliable forecasts.

Value for Investment

Credible, structured intelligence at a cost that makes strategic sense.

What Our Clients Say

"

My team needed the real numbers on AI spending for our Reinvention Services work. MarkWide delivered. No fluff, just a clear look at where the money is actually going. It saved us about three weeks of guesswork.

Accenture

"

We recently leaned on MarkWide Research for a deep dive into the evolving snacking habits within Southeast Asia. Their report on the premium biscuit segment was exceptionally detailed, providing us with the specific consumer sentiment data we needed to refine our regional flavor strategy. It wasn't just a data dump; the cultural nuances they captured helped us avoid several localization pitfalls.

Mondelez

Director of Global Consumer Insights

"

For a recent engagement in the automotive sector, we needed rigorous, independent verification of EV battery recycling capacities. MWR delivered a report that made our work easier. Their ability to segment the competitive landscape by chemical composition and regional throughput was exactly the kind of 'hard-to-find' intel that our team was looking for.

BCG

"

We were looking for a report on Xcelerator ecosystem's potential and got in touch with MarkWide's team through one of my old colleagues who worked with them in the past. Their research team was incredibly polite and were always available for us which was important for my team as this was a custom project. Their methodology for tracking industrial IoT adoption gave our R&D heads the clarity needed to prioritize our next-gen sensor development.

Siemens

Head of Industrial Digitalization

"

During a recent M&A project, we needed a fast, reliable breakdown of the Fintech landscape in Southeast Asia. MarkWide came through with a report that was actually readable and focused on the metrics that matter. It saved my team a good week of primary research, which, given our timelines, was a massive win.

KPMG

Advisory Partner

"

We tapped MarkWide Research for a deep dive into the ESG reporting software market. At Deloitte, our clients expect us to have the most current insights, and this report didn't disappoint. It provided a breakdown of the competitive field that was far more detailed than what we were expecting.

Deloitte

Lead Consultant, Sustainability Services

"

For our semiconductor division at Samsung, the supply chain forecast from MarkWide was incredibly useful. It provided a realistic outlook on raw material availability that helped us refine our production timelines. No fluff, just the data we needed to make a tough call.

Samsung

"

The value for our organization comes from three things: depth of research, specificity of segments and being easy to work with. As important as the first two are, the third can't be underestimated. MarkWide Research, maybe more than any other research vendor, wants to know what is top of mind for our team and what big questions we are grappling to answer. Their customer first approach and high value engagement model have given us great analysis and excellent value for money.

3M

"

I can share that it was a positive experience wherein MarkWide Research demonstrated flexibility to adapt to our needs and delivered an excellent report that fits all our requirements. Personally, I liked the timely follow up by the team and we will definitively reach out in case more research support is required.

VITO

Buy Now